Repeat-positive SARS-CoV-2 in a child with cancer.
Venkatraman Radhakrishnan, Devleena Gangopadhyay
Author Information
- Venkatraman Radhakrishnan: Department of Medical Oncology (Pediatric Oncology Division), Cancer Institute (WIA), Adyar, Chennai, India. ORCID
- Devleena Gangopadhyay: Department of Medical Oncology (Pediatric Oncology Division), Cancer Institute (WIA), Adyar, Chennai, India.
No abstract text available.
- JAMA Pediatr. 2021 Jan 1;175(1):73-80
[PMID: 32857112]
- EBioMedicine. 2020 Sep;59:102960
[PMID: 32853988]
- Am J Emerg Med. 2021 Jan;39:256.e1-256.e3
[PMID: 32703607]
- Colorectal Dis. 2020 Jun;22(6):611-620
[PMID: 32418307]
- Lancet. 2020 Mar 28;395(10229):1054-1062
[PMID: 32171076]
- J Med Virol. 2021 Jan;93(1):506-512
[PMID: 32644223]
- Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
[PMID: 32840608]
- New Microbes New Infect. 2020 Sep;37:100748
[PMID: 32843984]
Antimetabolites, Antineoplastic
Asymptomatic Diseases
COVID-19
Child, Preschool
Humans
Male
Mercaptopurine
Methotrexate
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
SARS-CoV-2
Antimetabolites, Antineoplastic
Mercaptopurine
Methotrexate
